[UPDATED JULY 18]

The exciting news was announced last week that pre-exposure prophylaxis has been shown to work for heterosexual men and women as well as MSM. This is HUGE for HIV prevention.

Below is a selection of news items and press releases we have collected on the two studies that reported out last week. In the comments feel free to share your reactions to this news.

Washington Post: Two studies show that drugs used to treat AIDS can be used to prevent HIV infection, too

EurekAlert (Microbicide Trials Network): VOICE study will continue as it considers what action to take after results of 2 trials

CDC: CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection among Heterosexuals

iPrEX News: Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex with Men

Wall Street Journal: AIDS Drugs Can Prevent Infection, Studies Show

AIDSMAP: Two major studies show that HIV drugs prevent infection

New Vision: Drugs prevent HIV infection up to 73%

Science Now: Anti-HIV Pills Show Powerful Effect Against AIDS

Reuters: 2-Once-daily AIDS pill can slash HIV infection risk

POZ: PrEP Reduces HIV Risk in Two Major Studies

PlusNews: HIV/AIDS: More proof that PrEP works

New Scientist: One cheap pill protects healthy people from HIV

The Daily Nation: Daily dose of drug ‘lowers risk of HIV infection’

Fit Perez: New Pill Could Prevent HIV

Project Inform: Project Inform urges government action following the positive results of two PrEP studies in heterosexual men and women

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article’s content, whether in support or in opposition.]